Literature DB >> 24374012

Structure and function of epigen, the last EGFR ligand.

Marlon R Schneider1, Yosef Yarden2.   

Abstract

Epigen is the latest addition to the mammalian family of EGFR ligands. Epigen was initially identified as a novel expressed sequence tag with homology to the EGF family by high throughput sequencing of a mouse keratinocyte complementary DNA library, and received its name for its ability to act as an epithelial mitogen. In vitro studies attributed to epigen several unique features, such as persistent and potent biological actions involving low affinity receptor binding, as well as sub-maximal receptor activation and inactivation. Similarly to the other EGFR ligands, the expression of epigen is up-regulated by hormones and in certain cancer types. While the biological functions of epigen remain to be uncovered, it appears to play a role in epidermal structures, such as the mammary gland and the sebaceous gland. The latter organ, in particular, was greatly enlarged in transgenic mice overexpressing epigen. Interestingly, mice lacking epigen develop and grow normally, probably due to functional compensation by other EGFR ligands. Future studies are likely to reveal the biological roles of the unique receptor binding properties of epigen, as well as its potential harnessing during disease.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; EGFR; ERBB family; Epigen; Gene knockout

Mesh:

Substances:

Year:  2013        PMID: 24374012      PMCID: PMC4037347          DOI: 10.1016/j.semcdb.2013.12.011

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  45 in total

1.  Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes.

Authors:  R Ebner; R Derynck
Journal:  Cell Regul       Date:  1991-08

2.  Epidermal growth factor. Location of disulfide bonds.

Authors:  C R Savage; J H Hash; S Cohen
Journal:  J Biol Chem       Date:  1973-11-25       Impact factor: 5.157

3.  Isolation from murine sarcoma cells of novel transforming growth factors potentiated by EGF.

Authors:  A B Roberts; M A Anzano; L C Lamb; J M Smith; C A Frolik; H Marquardt; G J Todaro; M B Sporn
Journal:  Nature       Date:  1982-02-04       Impact factor: 49.962

4.  Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration.

Authors:  Claudia Mitchell; Mary Nivison; Leslie F Jackson; Richard Fox; David C Lee; Jean S Campbell; Nelson Fausto
Journal:  J Biol Chem       Date:  2004-11-08       Impact factor: 5.157

5.  Mouse chromosomal location of three EGF receptor ligands: amphiregulin (Areg), betacellulin (Btc), and heparin-binding EGF (Hegfl).

Authors:  B G Pathak; D J Gilbert; C A Harrison; N C Luetteke; X Chen; M Klagsbrun; G D Plowman; N G Copeland; N A Jenkins; D C Lee
Journal:  Genomics       Date:  1995-07-01       Impact factor: 5.736

6.  Malignant peripheral nerve sheath tumor invasion requires aberrantly expressed EGF receptors and is variably enhanced by multiple EGF family ligands.

Authors:  Stephanie J Byer; Nicole M Brossier; Lafe T Peavler; Jenell M Eckert; Stacey Watkins; Kevin A Roth; Steven L Carroll
Journal:  J Neuropathol Exp Neurol       Date:  2013-03       Impact factor: 3.685

7.  Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.

Authors:  C Leann Hinkle; Susan W Sunnarborg; David Loiselle; Carol E Parker; Mary Stevenson; William E Russell; David C Lee
Journal:  J Biol Chem       Date:  2004-04-05       Impact factor: 5.157

8.  Engineering epidermal growth factor for enhanced mitogenic potency.

Authors:  C C Reddy; S K Niyogi; A Wells; H S Wiley; D A Lauffenburger
Journal:  Nat Biotechnol       Date:  1996-12       Impact factor: 54.908

9.  Amphiregulin, an epidermal growth factor receptor ligand, plays an essential role in the pathogenesis of transforming growth factor-β-induced pulmonary fibrosis.

Authors:  Yang Zhou; Jae-Young Lee; Chang-Min Lee; Won-Kyung Cho; Min-Jong Kang; Jonathan L Koff; Pyeong-Oh Yoon; Jeiwook Chae; Han-Oh Park; Jack A Elias; Chun Geun Lee
Journal:  J Biol Chem       Date:  2012-10-19       Impact factor: 5.157

Review 10.  The epidermal growth factor receptor ligands at a glance.

Authors:  Marlon R Schneider; Eckhard Wolf
Journal:  J Cell Physiol       Date:  2009-03       Impact factor: 6.384

View more
  12 in total

1.  Transgenic expression of human amphiregulin in mouse skin: inflammatory epidermal hyperplasia and enlarged sebaceous glands.

Authors:  Yong Li; Stefan W Stoll; Sahil Sekhon; Caroline Talsma; Maya I Camhi; Jennifer L Jones; Sylviane Lambert; Hue Marley; Laure Rittié; Marina Grachtchouk; Yi Fritz; Nicole L Ward; James T Elder
Journal:  Exp Dermatol       Date:  2016-01-12       Impact factor: 3.960

2.  miRNAs Are Required for Postinduction Stage Sweat Gland Development.

Authors:  Chang-Yi Cui; Yulan Piao; Dean P Campbell; Ryuga Ishii; Marc Michel; Alexei Sharov; David Schlessinger
Journal:  J Invest Dermatol       Date:  2017-03-09       Impact factor: 8.551

3.  Overexpression of epigen during embryonic development induces reversible, epidermal growth factor receptor-dependent sebaceous gland hyperplasia.

Authors:  Maik Dahlhoff; Daniela Frances; Jennifer E Kloepper; Ralf Paus; Matthias Schäfer; Catherin Niemann; Marlon R Schneider
Journal:  Mol Cell Biol       Date:  2014-06-02       Impact factor: 4.272

4.  Novel EGFR-specific immunotoxins based on panitumumab and cetuximab show in vitro and ex vivo activity against different tumor entities.

Authors:  Judith Niesen; Christoph Stein; Hannes Brehm; Grit Hehmann-Titt; Rolf Fendel; Georg Melmer; Rainer Fischer; Stefan Barth
Journal:  J Cancer Res Clin Oncol       Date:  2015-04-22       Impact factor: 4.322

Review 5.  EGF receptor ligands: recent advances.

Authors:  Bhuminder Singh; Graham Carpenter; Robert J Coffey
Journal:  F1000Res       Date:  2016-09-08

6.  Dysregulated EGFR pathway in serum in early-stage breast cancer patients: A case control study.

Authors:  Ina Mathilde Kjær; Dorte Aalund Olsen; Ivan Brandslund; Troels Bechmann; Erik Hugger Jakobsen; Søren Bie Bogh; Jonna Skov Madsen
Journal:  Sci Rep       Date:  2020-04-21       Impact factor: 4.379

7.  Natural Products as Chemopreventive Agents by Potential Inhibition of the Kinase Domain in ErbB Receptors.

Authors:  Maria Olivero-Acosta; Wilson Maldonado-Rojas; Jesus Olivero-Verbel
Journal:  Molecules       Date:  2017-02-17       Impact factor: 4.411

Review 8.  A novel ligand-receptor relationship between families of ribonucleases and receptor tyrosine kinases.

Authors:  Ying-Nai Wang; Heng-Huan Lee; Mien-Chie Hung
Journal:  J Biomed Sci       Date:  2018-11-19       Impact factor: 8.410

Review 9.  Advances in Targeting the Epidermal Growth Factor Receptor Pathway by Synthetic Products and Its Regulation by Epigenetic Modulators As a Therapy for Glioblastoma.

Authors:  Muhammad Nadeem Abbas; Saima Kausar; Feng Wang; Yongju Zhao; Hongjuan Cui
Journal:  Cells       Date:  2019-04-12       Impact factor: 6.600

10.  Transcriptome analysis of HPV-induced warts and healthy skin in humans.

Authors:  Laith N Al-Eitan; Amneh H Tarkhan; Mansour A Alghamdi; Firas A Al-Qarqaz; Hadeel S Al-Kofahi
Journal:  BMC Med Genomics       Date:  2020-03-09       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.